Hyphens Pharma to launch Maruho’s shingles drug in ASEAN

  • 📰 SBRMagazine
  • ⏱ Reading Time:
  • 55 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

pstrongIt will commercialise Amenalief® Tab 200mg in 10 ASEAN countries./strong/p pJapan-based pharma company Maruho has granted a href="https://sbr.com.

In Singapore, more than 90% of adults over 50 carry Varicella-Zoster Virus type 2 , putting older individuals at a higher risk of developing shingles.

Hyphens Pharma said Maruho's medication"has a novel mechanism of action that inhibits the proliferation of VZV by inhibiting the activity of the helicase-primase complex, which is essential for viral DNA replication." "Amenalief® has proven to be effective against VZV when administered once a day for seven days, versus standard therapies that require either three or five times dosing per day. Unlike other oral therapies, Amenalief® does not require any dosage adjustment in patients with renal impairment, a common concern in older patients," Hyphens Pharma said in a bourse filing....there are many ways you can work with us to advertise your company and connect to your customers.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 13. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Improved sales boost Hyphens Pharma Q1 profit by 97.6%pstrongThe Specialty Pharma Principals led the increase in revenue./strong/p pHyphens Pharma International nearly doubled its net profit for the first quarter of 2024 (Q1 2024) to $2.7m backed by robust revenue during the period. /p pIn a bourse filing, the company said revenue was up 44.
Source: SBRMagazine - 🏆 13. / 51 Read more »

Pharma giant AstraZeneca to build $2 billion manufacturing facility in SingaporeIt will be the company's first such facility here.
Source: The Straits Times - 🏆 8. / 63 Read more »